ArticleBJR open2025
Development of a biological at-risk volume using apparent diffusion coefficient for parotid-sparing radiation therapy planning.
Article in BJR open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Xerostomia toxicity continues to contribute towards a decrease in quality of life in head and neck cancer patients. Diffusion weighted MRI and the associated apparent diffusion coefficient (ADC) may identify the radiosensitive region within the parotid gland (PG). This study retrospectively assesses the feasibility of using percentile threshold values from the ADC map to generate a biological at-risk volume (BRV). The location and distribution of BRV are evaluated across the PG. Methods: Image registration between the planning CT and MRI-simulation images was performed and reviewed to ensure accurate translation of ADC data when contouring the PG. Histogram analysis was undertaken using the 20th, 30th, and 50th percentile ADC values of each contoured PG to form the BRV. The whole PG was split into 8 anatomical sectors at a common intersection point to evaluate the distribution of BRV throughout. Results: The BRV distribution for each percentile was mapped across the whole contoured PG and each anatomical sector contour. The largest distribution was predominantly found in the superolateral sectors. Conclusions: The 20th and 30th percentile ADC values can be used to form a BRV of the PG. The location of the BRV distribution indicates a potential relationship between ADC thresholds and the functional region of the PG. Advances in knowledge: The BRV is located in a favourable position within the PG and could be used to further spare this salivary gland during dose optimization. The feasibility of this approach will be explored in a future retrospective dosimetry study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.